- Home
- A-Z Publications
- Current Drug Targets
- Previous Issues
- Volume 21, Issue 11, 2020
Current Drug Targets - Volume 21, Issue 11, 2020
Volume 21, Issue 11, 2020
-
-
A Review of Aberrant DNA Methylation and Epigenetic Agents Targeting DNA Methyltransferases in Endometriosis
Authors: Leilei Ding, Li Yang, Chenchen Ren, Huawen Zhang, Jie Lu, Senyan Wang, Zimeng Wu and Yanan YangBackground: Endometriosis (EMS) is a gynecological disease defined by the translocation and growth of endometrial tissue in other tissues or organs outside the uterus. Its clinical manifestations are dysmenorrhea, irregular menstruation, and even infertility. Although EMS is a benign disease, it has the characteristics of malignant tumor and the potential of malignant transformation. Recent studies have found that EM Read More
-
-
-
N6-methyladenine RNA Modification (m6A): An Emerging Regulator of Metabolic Diseases
Authors: Hui Zhong, Hui-Fang Tang and Yin KaiN6-methyladenine RNA modification (m6A) is an RNA methylation modification catalyzed by methyltransferase at the 6th position nitrogen atom of adenine (A), which is the most common chemical modification of eukaryotic messenger RNA (mRNA). Recently, m6A has been found to play an important role in the dynamic regulation of RNA, which is crucial for some physiological and pathophysiological processes such as adipo Read More
-
-
-
Epigenetic Therapies and Potential Drugs for Treating Human Cancer
Authors: Shi-qi Lin and Xia LiEpigenetic modifications ensure the maintenance of normal cellular functions, and their dysregulation is frequently found in many disease states, including cancer. Nowadays, the most studied epigenetic dysregulation associated with tumorigenesis, cancer progression and metastasis refers to the variations in DNA methylation, histone modification and chromatin structure. The development of novel agents targeting these proc Read More
-
-
-
Nanoparticle-based Drug Delivery Systems for Targeted Epigenetics Cancer Therapy
Authors: Fengqian Chen, Yunzhen Shi, Jinming Zhang and Qi LiuThis review summarizes the epigenetic mechanisms of deoxyribonucleic acid (DNA) methylation, histone modifications in cancer and the epigenetic modifications in cancer therapy. Due to their undesired side effects, the use of epigenetic drugs as chemo-drugs in cancer therapies is limited. The drug delivery system opens a door for minimizing these side effects and achieving greater therapeutic benefits. The limitations of curre Read More
-
-
-
The Epigenetic Modification of Epigallocatechin Gallate (EGCG) on Cancer
Authors: Linqi Yang, Wenqi Zhang, Saiyam Chopra, Deeepjyot Kaur, Huibing Wang, Meng Li, Pingping Chen and Wei ZhangAmong the major components of green tea, epigallocatechin-3-gallate (EGCG) is the most effective for its anti-cancer characteristics. The bulk of studies provide the mechanisms of suppressive function of EGCG are involved in alteration of cancer cell cycle, development, and apoptosis through activation/inhibition of several signal pathways. Another mechanism that explains the multiple effects exerted by EGCG in cance Read More
-
-
-
An Insight into the Current Perspective and Potential Drug Targets for Visceral Leishmaniasis (VL)
Authors: Rani Mansuri, Jagbir Singh and Anupama DiwanLeishmaniasis is one of the six entities on the list of most important diseases of the World Health Organization/Tropical Disease Research (WHO/TDR). After Malaria, it is one of the most prevalent and lethal parasitic diseases. VL is the fatal form of this disease, especially if left untreated. The drugs that are currently available for the treatment of VL are expensive, toxic, or no longer effective, especially in ende Read More
-
-
-
Current and Future Prospective of a Versatile Moiety: Imidazole
Authors: Nidhi Rani, Praveen Kumar, Randhir Singh, Damião P. de Sousa and Prerna SharmaImidazole containing compounds have been a very much explored field since ancient times. Subsequently, it constitutes a significant moiety for the new drug development. A variety of compounds having imidazole moiety have been synthesized, evaluated and marketed for the treatment of various diseases such as antifungal, antiepileptic, ACE inhibitors and so on, as shown in the figure. The search for imidazole containing c Read More
-
Volumes & issues
-
Volume 26 (2025)
-
Volume 25 (2024)
-
Volume 24 (2023)
-
Volume 23 (2022)
-
Volume 22 (2021)
-
Volume 21 (2020)
-
Volume 20 (2019)
-
Volume 19 (2018)
-
Volume 18 (2017)
-
Volume 17 (2016)
-
Volume 16 (2015)
-
Volume 15 (2014)
-
Volume 14 (2013)
-
Volume 13 (2012)
-
Volume 12 (2011)
-
Volume 11 (2010)
-
Volume 10 (2009)
-
Volume 9 (2008)
-
Volume 8 (2007)
-
Volume 7 (2006)
-
Volume 6 (2005)
-
Volume 5 (2004)
-
Volume 4 (2003)
-
Volume 3 (2002)
-
Volume 2 (2001)
-
Volume 1 (2000)
Most Read This Month
Article
content/journals/cdt
Journal
10
5
false
en
